Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-25

FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the original application for a fixed-dose combination eye drop containing brimonidine tartrate and timolol maleate, manufactured by Alembic Pharmac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine tartrate and timolol maleate (brimonidine tartrate and timolol maleate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)